Vor Biopharma Inc. Common Stock (VOR)

About VOR

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Website

www.vorbio.com/

Fundamentals

Market cap

$1.28B

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-293.09

Dividend yield

—

Beta

1.63

Avg. volume

—

Vor Biopharma Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• VOR

  Vor Biopharma Inc. Common Stock

  $22.66

  ▼ 3.70%
  Market cap $1.28BP/E —
  $6.5$49.95
• NVAX

  Novavax Inc. Common Stock

  $9.27

  ▲ 2.43%
  Market cap $1.27BP/E —
  $6.2$11.97
• IMTX

  Immatics N.V. Ordinary Shares

  $9.45

  ▲ 0.91%
  Market cap $1.26BP/E —
  $5.05$12.41
• INBX

  Inhibrx Biosciences Inc. Common Stock

  $123.93

  ▼ 0.00%
  Market cap $1.26BP/E —
  $26.19$155.29
• GLUE

  Monte Rosa Therapeutics Inc. Common Stock

  $13.37

  ▼ 6.63%
  Market cap $1.33BP/E —
  $4.6$25.77
• ALVO

  Alvotech Ordinary Shares

  $4.95

  ▲ 1.43%
  Market cap $1.19BP/E —
  $2.94$9.25
• MGTX

  MeiraGTx Holdings plc Ordinary Shares

  $13.8

  ▼ 2.40%
  Market cap $1.18BP/E 17.21
  $6.62$15.35

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Wedbush Maintains Neutral on Vor Biopharma, Raises Price Target to $27
  benzinga · 8/12/2026

Institutional Ownership

March 31, 2026

Total shares held

40.42M

Total value held

$715.96M

Institutional holders

77